Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
October 18, 2021 17:45 ET
|
Lucid Diagnostics Inc.
NEW YORK, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq:...